Skip to main content

Advertisement

Springer Nature Link
Log in

An atomistic model of passive membrane permeability: application to a series of FDA approved drugs

  • Published:
Journal of Computer-Aided Molecular Design Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

We apply an atomistic model of passive membrane permeability to a series of weakly basic drugs. The computational model uses conformational sampling in combination with an all-atom force field and implicit solvent model to estimate relative passive membrane permeabilities. The model does not require the use of training data for rank-ordering compounds, and as such represents a different approach from the more commonly employed QSPR models. We compare the computational results to previously published experimental PAMPA and Caco-2 permeabilities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Bemporad D, Luttmann C, Essex JW (2005) Biochim Biophys Acta 1718:1

    Article  CAS  Google Scholar 

  2. Rezai T, Bock JE, Zhou MV, Kalyanaraman C, Lokey RS, Jacobson MP (2006) J Am Chem Soc 128:14073

    Article  CAS  Google Scholar 

  3. Rezai T, Yu B, Millhauser GL, Jacobson MP, Lokey RS (2006) J Am Chem Soc 128:2510

    Article  CAS  Google Scholar 

  4. Fujikawa M, Ano R, Nakao K, Shimizu R, Akamatsu M (2005) Bioorg Med Chem 13:4721

    Article  CAS  Google Scholar 

  5. Bemporad D, Luttmann C, Essex JW (2004) Biophys J 87:1

    Article  CAS  Google Scholar 

  6. Conradi RA, Hilgers AR, Ho NFH, Burton PS (1991) Pharm Res 8:1453

    Article  CAS  Google Scholar 

  7. Huque FT, Box K, Platts JA, Comer J (2004) Eur J Pharm Sci 23:223

    Article  CAS  Google Scholar 

  8. Ano R, Kimura Y, Shima M, Matsuno R, Ueno T, Akamatsu M (2004) Bioorg Med Chem 12:257

    Article  CAS  Google Scholar 

  9. Winiwarter S, Ax F, Lennernas H, Hallberg A, Pettersson C, Karlen A (2003) J Mol Graph Model 21:273

    Article  CAS  Google Scholar 

  10. Di Fenza A, Alagona G, Ghio C, Leonardi R, Giolitti A, Madami A (2007) J Comput Aided Mol Des

  11. Ekins S, Rose J (2002) J Mol Graph Model 20:305

    Article  CAS  Google Scholar 

  12. Refsgaard HH, Jensen BF, Brockhoff PB, Padkjaer SB, Guldbrandt M, Christensen MS (2005) J Med Chem 48:805

    Article  CAS  Google Scholar 

  13. Krarup LH, Christensen IT, Hovgaard L, Frokjaer S (1998) Pharm Res 15:972

    Article  CAS  Google Scholar 

  14. Ekins S, Waller CL, Swaan PW, Cruciani G, Wrighton SA, Wikel JH (2000) J Pharmacol Toxicol Methods 44:251

    Article  CAS  Google Scholar 

  15. Ekins S, Durst GL, Stratford RE, Thorner DA, Lewis R, Loncharich RJ, Wikel JH (2001) J Chem Inf Comput Sci 41:1578

    Article  CAS  Google Scholar 

  16. Yamashita F, Wanchana S, Hashida M (2002) J Pharm Sci 91:2230

    Article  CAS  Google Scholar 

  17. Malkia A, Murtomaki L, Urtti A, Kontturi K (2004) Eur J Pharm Sci 23:13

    Article  CAS  Google Scholar 

  18. Fujiwara S, Yamashita F, Hashida M (2002) Int J Pharm 237:95

    Article  CAS  Google Scholar 

  19. Stouch TR, Kenyon JR, Johnson SR, Chen XQ, Doweyko A, Li Y (2003) J Comput Aided Mol Des 17:83

    Article  CAS  Google Scholar 

  20. Palm K, Luthman K, Ungell A-L, Strandlund G, Artrusson P (1996) J Pharm Sci 85:32

    Article  CAS  Google Scholar 

  21. Avdeef A, Artursson P, Neuhoff S, Lazorova L, Grasjo J, Tavelin S (2005) Eur J Pharm Sci 24:333

    Article  CAS  Google Scholar 

  22. Jorgensen WL, Tiradorives J (1988) J Am Chem Soc 110:1666

    Article  Google Scholar 

  23. Kaminski GA, Friesner RA, Tirado-Rives J, Jorgensen WL (2001) J Phys Chem B 105:6474

    Article  CAS  Google Scholar 

  24. Ghosh A, Rapp CS, Friesner RA (1998) J Phys Chem B 102:10983

    Article  CAS  Google Scholar 

  25. Luo R, Head MS, Given JA, Gilson MK (1999) Biophys Chem 78:183

    Article  CAS  Google Scholar 

  26. Goodwin JT, Mao B, Vidmar TJ, Conradi RA, Burton PS (1999) J Pept Res 53:355

    Article  CAS  Google Scholar 

  27. Pohorille A, New MH, Schweighofer K, Wilson MA (1999) Curr Topics Membr 48:49

    Article  CAS  Google Scholar 

  28. Walter A, Gutknecht J (1986) J Membr Biol 90:207

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by NIH grant AI035707. MPJ is a consultant to Schrödinger, Inc.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Chemistry, UCSF, San Francisco, CA, 94158-2517, USA

    Chakrapani Kalyanaraman & Matthew P. Jacobson

Authors
  1. Chakrapani Kalyanaraman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Matthew P. Jacobson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthew P. Jacobson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kalyanaraman, C., Jacobson, M.P. An atomistic model of passive membrane permeability: application to a series of FDA approved drugs. J Comput Aided Mol Des 21, 675–679 (2007). https://doi.org/10.1007/s10822-007-9141-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10822-007-9141-z

Keywords